Answers are grounded in this paper and cite their sources.
Commentary discusses targeting biomolecular condensates to enhance cancer therapy, suggesting novel strategies for treatment.
Biomolecular condensates formed via phase separation are emerging targets for pharmacologic or genetic manipulation for cancer therapy. In this commentary, we envisage that further deciphering the composition and the physicochemical properties of oncogenic condensates will provide unprecedented opportunities to develop novel strategies for cancer chemotherapy and immunotherapy.
No takes yet. Share an insight, caveat, or question.
You et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: